Updates in Treatment of Unresectable Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is the sixth-leading cause of cancer-related death in the United States, with an estimated 41,630 new diagnoses...
hepatocellular
Health inequalities in hepatocellular carcinoma surveillance, diagnosis, treatment, and survival in the United Kingdom: a scoping review
Burton A, Tataru D, Driver RJ, Bird TG, Huws D, Wallace D, et al. Primary liver cancer in the UK:...
Phase 2 Study Evaluates Serplulimab Plus HLX04 as First-Line Treatment for Advanced Hepatocellular Carcinoma
An open-label, multicenter phase 2 study (NCT03973112) conducted in China aimed to investigate the safety and initial effectiveness of serplulimab...
Helio Genomics’ Methylation Model Score for Assessing Prognosis and Treatment Response in Patients with Hepatocellular Carcinoma Presented as Top Abstract at the 2024 San Antonio Liver Cancer Symposium
IRVINE, Calif., Oct. 14, 2024 (GLOBE NEWSWIRE) -- Helio Genomics ("Helio” or "the Company”), an AI-driven healthcare company specializing in...
Ultrasound techniques for the surveillance, diagnosis, and treatment of hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is a primary malignancy of the liver and one of the leading causes of cancer-related deaths worldwide....
Unresectable Hepatocellular Carcinoma: Global Market
Dublin, May 07, 2024 (GLOBE NEWSWIRE) -- The "Unresectable Hepatocellular Carcinoma Global Market Report 2024" report has been added to...
